What screening is recommended for settings that include immunocompromised patients?

Varicella Zoster Screening is recommended for settings that include immunocompromised patients because individuals with weakened immune systems are at a higher risk for severe complications from infections, including varicella (chickenpox). Varicella can lead to serious health issues in these patients, such as pneumonia or disseminated infections. Therefore, screening can help identify individuals who are either susceptible to varicella or may have had exposure, allowing for timely intervention, such as vaccination of susceptible individuals who are not currently infected or treatment for those who have been exposed.

In comparison, while COVID-19 testing, STD screening, and influenza screening are important in their own contexts, they do not specifically target the unique vulnerabilities associated with varicella in immunocompromised patients. Monitoring for varicella is particularly critical since it can be a more immediate and severe threat in this population.